Streetbeat News

Stock Prices

BMY

LIAN

LianBio's shares are experiencing an upward trend following the announcement of an agreement with Bristol Myers Squibb for mavacamten in China and other Asian markets.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 6:11 pm

DIA

GOOGL

IWM

QQQ

SPY

Major indexes are down due to weakness in Alphabet after its Q3 earnings report.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 6:11 pm

MMM

3M Co (NYSE:MMM) reported better-than-expected Q3 FY23 results and raised its FY23 earnings guidance. Despite this, 3M shares fell 0.9% to trade at $89.32. Post-earnings, Barclays, Citigroup, JP Morgan, and RBC Capital revised their price targets on 3M.

Portfolio Pulse from Lisa Levin

October 25, 2023 | 6:11 pm

AMRN

Jefferies has downgraded Amarin's stock from Buy to Hold and reduced its price target from $3 to $1, causing the shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 6:10 pm

HCSG

Healthcare Services Group (HCSG) reported worse-than-expected Q3 financial results, leading to a drop in its share price.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 6:08 pm

FTCH

Farfetch's stock has been downgraded from Buy to Sell by Societe Generale, with a new price target of $1.5. This has led to a decrease in Farfetch's share price.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 6:08 pm

SAVA

Cassava Sciences announced that MRI data suggests its drug simufilam is not associated with amyloid-related imaging abnormalities, leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 6:07 pm

SRRK

Jefferies has upgraded Scholar Rock's stock from Hold to Buy and set a price target of $20. This has resulted in Scholar Rock's shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 6:03 pm

SHEL

Shell PLC (NYSE:SHEL) is planning to cut around 15% of the workforce in its low-carbon solutions division and reduce its exposure to the hydrogen business. The move is part of a strategy to focus on higher-margin projects, steady oil output, and grow natural gas production. The company plans to cut 200 jobs in 2024 and is currently reviewing 130 positions. The shares of Shell are trading higher by 0.25% at $66.83.

Portfolio Pulse from Lekha Gupta

October 25, 2023 | 6:03 pm

PTCT

PTC Therapeutics (NASDAQ:PTCT) is set to release its quarterly earnings report on October 26, 2023. Analysts estimate an earnings per share (EPS) of $-1.17. The company's stock performance has been generally negative over the past year, with shares down 48.15%. The company's earnings performance and guidance will be key factors affecting the stock price.

Portfolio Pulse from Benzinga Insights

October 25, 2023 | 6:02 pm